Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study-Reference-Cited by-同舟云学术

Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study

Published:2014-08 Issue:2 Volume:66 Page:330-336
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

van Soest Robert J.,de Morrée Ellen S.,Shen Liji,Tannock Ian F.,Eisenberger Mario A.,de Wit Ronald

Publisher

Elsevier BV

Subject

Urology

Reference25 articles.

1. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study;Berthold;J Clin Oncol,2008

4. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;N Engl J Med,2013

5. 20-year outcomes following conservative management of clinically localized prostate cancer;Albertsen;JAMA,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Study #7: PSMA-617;Radiopharmaceutical Therapy;2023

2. UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive prostate cancer;Urologic Oncology: Seminars and Original Investigations;2022-12

3. Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective Study;Anticancer Research;2022-10

4. Cost-effectiveness of olaparib, a PARP inhibitor, for patients with metastatic castration-resistant prostate cancer in China and United States;Annals of Translational Medicine;2022-08

5. Surface-enhanced Raman spectroscopy of serum predicts sensitivity to docetaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer;Journal of Innovative Optical Health Sciences;2021-06-23